|
|
|
|
|
|
|
|
RxList
WARNING
NEUTROPENIA
Do not administer ABRAXANE therapy to patients who
have baseline neutrophil counts of less than 1,500 cells/mm³. In order to monitor
the occurrence of bone marrow suppression, primarily neutropenia, which may be
severe and result in infection, it is recommended that frequent peripheral
blood cell counts be performed on all patients receiving ABRAXANE [see
CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS and ADVERSE REACTIONS].Note: An albumin form of paclitaxel may substantially affect a drug's functional properties relative to those of drug in solution. DO NOT SUBSTITUTE FOR OR WITH OTHER PACLITAXEL FORMULATIONS.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.